Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
debts
Biotech
Impel seeks loan leniency to avoid asset sale or bankruptcy
Impel warned it may have to sell assets or file for bankruptcy if it is unable to restructure its credit deal and secure fresh funding.
Nick Paul Taylor
Aug 16, 2023 8:09am
Baxter brokers $4.25B sale of biopharma solutions segment
May 8, 2023 12:12am
Time may be running out for anti-aging biotech AgeX
Aug 15, 2022 11:20am
Radiotherapy tech maker RefleXion takes on $125M loan
Jul 7, 2022 10:53am
Medtronic ties up first closing of $50M Acutus asset buy
Jul 1, 2022 12:00pm
Bioventus nixes $415M funding plan for CartiHeal acquisition
May 11, 2022 10:40am